Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-02-25 @ 7:27 PM
Study NCT ID:
NCT02105350
Status:
WITHDRAWN
Last Update Posted:
2018-02-19
First Post:
2014-04-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
Sponsor:
University Health Network, Toronto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-02
First Submit QC Date:
None
Study First Post Date:
2014-04-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-14
Last Update Post Date:
2018-02-19
Last Update Post Date Type:
ACTUAL